Table 1.

Clinicopathological data for MSI+ CRCs analyzed in-lab

Clinicopathological parameters	Norwegian series I (n = 78)		Norwegian series II (n = 31)	VICTOR (n = 81)
	All patients	Exome sequenced (n = 33)
Patient age at diagnosis (years)
Mean	75	74	66	65
Min	37	37	26	38
Max	93	93	92	89
Patient gender
Female	55	23	18	45
Male	23	10	13	36
Tumor localization
Right	68	31	20	66
Left	6	1	7	13
Rectum	4	1	4	-
Unknown	-	-	-	2
Tumor stage
I	16	1	3	-
II	42	23	17	54
III	15	9	8	27
IV	5	-	3	-
5-year survival rates
Overall	71%	85%	83%	82%
Relapse-free	70%	82%	72%	NA

NA not available